Stock

Nasdaq:

DEPO

Price:

3.75 -0.15

Volume:

274,832

20 minute delay

In The News

July 23, 2008 Depomed's ProQuin(R) XR Achieves First Marketing Authorization in Europe

July 23, 2008 The Michael J. Fox Foundation Awards Depomed a Preclinical Development Grant for Levodopa/Carbidopa in Parkinson's Disease

July 22, 2008 Santarus and Depomed Announce U.S. Promotion Agreement for GLUMETZA Prescription Products

July 17, 2008 Depomed to Announce Second Quarter 2008 Financial Results on July 31, 2008

July 9, 2008 Depomed Achieves Tier 2 Reimbursement Status for Glumetza(R) With CVS Caremark